ATC level 2
L04Immunosuppressants
- Molecules
- 87
- Subgroups
- 1
ATC L04 (Immunosuppressants) is a level 2 group in the anatomical therapeutic chemical classification. The catalogue lists 87 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under L04.
- AbataceptOrphanSelective T Cell Costimulation Modulator4 presentations2 brandsL04AA24
- AdalimumabOrphanAntibodies32 presentations23 brandsL04AB04
- AlemtuzumabOrphanCD52-directed Cytolytic Antibody2 presentations3 brandsL01XC04
- AnakinraOrphanInterleukin-1 Receptor Antagonist1 presentation1 brandL04AC03
- AnifrolumabBiologicType I Interferon Receptor Antagonist2 presentations2 brandsL04AG11
- ApremilastOrphanPhosphodiesterase 4 Inhibitor5 presentations3 brandsL04AA32
- AvacopanOrphanComplement 5a Receptor Antagonist1 presentation1 brandL04
- AzathioprinePurine Antimetabolite8 presentations3 brandsL04AX01
- BaricitinibJanus Kinase Inhibitor3 presentations2 brandsL04AF02
- BasiliximabOrphanInterleukin-2 Receptor Blocking Antibody1 presentation2 brandsL04AC02
- BelataceptOrphanSelective T Cell Costimulation Blocker1 presentation2 brandsL04AA28
- BelimumabBiologicB Lymphocyte Stimulator-specific Inhibitor2 presentations2 brandsL04AG04
- BelumosudilOrphan1 presentation2 brandsL04AA48
- BimekizumabBiologic2 presentations2 brandsL04AC
- BrodalumabBiologicAntibodies1 presentation2 brandsL04AC12
- CanakinumabOrphan1 presentation2 brandsL04AC08
- Certolizumab pegolBiologicTumor Necrosis Factor Blocker2 presentations2 brandsL04AB05
- CladribinePurine Antimetabolite4 presentations3 brandsL01BB04
- CrovalimabOrphanComplement C5 Inhibitor1 presentation2 brandsL04AJ07
- CyclosporineOrphanCalcineurin Inhibitor Immunosuppressant25 presentations13 brandsL04AD01
- DanicopanOrphanComplement Factor D Inhibitor2 presentations2 brandsL04AJ09
- DeucravacitinibTyrosine Kinase 2 Inhibitor1 presentation2 brandsL04AF07
- Dimethyl7 presentations6 brandsL04AX07
- Diroximel1 presentation2 brandsL04AX07
- EculizumabOrphanComplement Inhibitor3 presentations6 brandsL04AJ01
- Efgartigimod alfaOrphanNeonatal Fc Receptor Blocker1 presentation1 brandL04AA58
- EmapalumabOrphanInterferon gamma Blocker7 presentations1 brandL04AG09
- EtanerceptOrphanTumor Necrosis Factor Blocker2 presentations6 brandsL04AB01
- EtrasimodSphingosine 1-phosphate Receptor Modulator1 presentation2 brandsL04AE05
- EverolimusOrphanKinase Inhibitor30 presentations7 brandsL01XE10
- Filgotinib1 brandL04AF04
- FingolimodSphingosine 1-phosphate Receptor Modulator3 presentations4 brandsL04AE01
- GolimumabOrphanTumor Necrosis Factor Blocker3 presentations5 brandsL04AB06
- GuselkumabBiologicInterleukin-23 Antagonist3 presentations2 brandsL04AC16
- Icotrokinra1 presentation2 brandsL04AC28
- ImlifidaseOrphan1 brandL04AA
- InebilizumabOrphanCD19-directed Cytolytic Antibody1 presentation2 brandsL04AA
- InfliximabOrphanTumor Necrosis Factor Blocker7 presentations9 brandsL04AB02
- IptacopanOrphanComplement Factor B Inhibitor1 presentation2 brandsL04A
- IxekizumabBiologicInterleukin-17A Antagonist3 presentations2 brandsL04AC13
- LeflunomideAntirheumatic Agent5 presentations5 brandsL04AK01
- LenalidomideOrphanThalidomide Analog12 presentations6 brandsL04AX04
- MepolizumabOrphanInterleukin-5 Antagonist3 presentations2 brandsL04AC06
- MethotrexateOrphanFolate Analog Metabolic Inhibitor28 presentations7 brandsL01BA01
- MirikizumabOrphanInterleukin-23 Antagonist4 presentations2 brandsL04AC
- MycophenolateAntimetabolite Immunosuppressant13 presentations7 brandsL04AA06
- Mycophenolic acidAntimetabolite Immunosuppressant2 presentationsL04AA06
- NatalizumabBiologicIntegrin Receptor Antagonist2 presentations3 brandsL03AD
- NerandomilastOrphan2 presentations2 brandsL04AA61
- NipocalimabOrphan2 presentations2 brandsL04AL03
- OcrelizumabBiologicAntibodies1 presentation2 brandsL04AG08
- OfatumumabOrphanCD20-directed Cytolytic Antibody1 presentation2 brandsL01FA02
- OzanimodSphingosine 1-phosphate Receptor Modulator3 presentations4 brandsL04AA38
- PegcetacoplanOrphanComplement Inhibitor2 presentations3 brandsL04AJ03
- PirfenidoneOrphanPyridone6 presentations4 brandsL04AX05
- PomalidomideOrphanThalidomide Analog8 presentations7 brandsL04AX06
- PonesimodSphingosine 1-phosphate Receptor Modulator2 presentations2 brandsL04AE04
- RavulizumabOrphanComplement Inhibitor2 presentations2 brandsL04AA43
- RemibrutinibKinase Inhibitor1 presentation2 brandsL04AA60
- RilonaceptOrphan1 presentation1 brandL04AC04
- RisankizumabOrphanInterleukin-23 Antagonist6 presentations2 brandsL04AC18
- RitlecitinibKinase Inhibitor1 presentation2 brandsL04AF08
- RozanolixizumabOrphanNeonatal Fc Receptor Blocker4 presentations2 brandsL04AL02
- SarilumabBiologicInterleukin-6 Receptor Antagonist2 presentations2 brandsL04AC14
- SatralizumabOrphan2 presentations2 brandsL04AC
- SecukinumabBiologicInterleukin-17A Antagonist4 presentations2 brandsL04AC10
- SiltuximabOrphanInterleukin-6 Antagonist2 presentations2 brandsL04AC11
- SiponimodSphingosine 1-phosphate Receptor Modulator3 presentations2 brandsL04
- SirolimusOrphanKinase Inhibitor6 presentations4 brandsL04AH01
- SpesolimabOrphanInterleukin-36 Receptor Antagonist6 presentations3 brandsL04AC22
- SutimlimabOrphanClassical Complement Pathway Inhibitor1 presentation1 brandL04AJ04
- TacrolimusOrphanCalcineurin Inhibitor Immunosuppressant21 presentations8 brandsD11AH01
- Tegomil1 brandL04AX10
- TeprotumumabOrphanInsulin-like Growth Factor-1 Receptor Inhibitor1 presentation2 brandsL04AG13
- TeriflunomidePyrimidine Synthesis Inhibitor4 presentations4 brandsL04AK02
- ThalidomideOrphanDecreased Immunologically Active Molecule Activity4 presentations3 brandsL04AX02
- TildrakizumabBiologicInterleukin-23 Antagonist2 presentations2 brandsL04AC17
- TocilizumabOrphanInterleukin-6 Receptor Antagonist17 presentations10 brandsL04AC07
- TofacitinibJanus Kinase Inhibitor12 presentations3 brandsL04AF01
- Tolebrutinib1 brandL04AA62
- UblituximabBiologicCD20-directed Cytolytic Antibody1 presentation2 brandsL04
- UpadacitinibOrphanJanus Kinase Inhibitor4 presentations2 brandsL04AA44
- UstekinumabOrphanInterleukin-12 Antagonist32 presentations23 brandsL04AC05
- VedolizumabBiologicIntegrin Receptor Antagonist3 presentations3 brandsL04AA33
- Vilobelimab1 brandL04AJ10
- VoclosporinCalcineurin Inhibitor Immunosuppressant1 presentation2 brandsL04AD03
- ZilucoplanOrphanComplement Inhibitor3 presentations2 brandsL04AJ06
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.